Suppr超能文献

iStent Inject(第二代小梁微通道分流器)与超声乳化白内障吸除术联合应用于开角型青光眼和白内障的手术治疗:1 年结果。

iStent Inject (Second-generation Trabecular Microbypass) Versus Nonpenetrating Deep Sclerectomy in Association With Phacoemulsification for the Surgical Treatment of Open-angle Glaucoma and Cataracts: 1-Year Results.

机构信息

Paletta Guedes Eye Institute.

Federal University of Juiz de Fora, Juiz de Fora, MG, Brazil.

出版信息

J Glaucoma. 2020 Oct;29(10):905-911. doi: 10.1097/IJG.0000000000001576.

Abstract

PRECIS

Both nonpenetrating deep sclerectomy (NPDS) and iStent inject are safe and effective when combined with phacoemulsification. The NPDS group presented lower final intraocular pressure (IOP); however, more postoperative intervention and longer recovery time was required.

AIM

The aim of this study was to assess the 1-year efficacy and safety of second-generation trabecular microbypass stent implantation (iStent inject) versus NPDS in association with phacoemulsification (Phaco) for the concomitant surgical treatment of open-angle glaucoma and cataracts.

MATERIALS AND METHODS

This was a single-center longitudinal retrospective comparative study of eyes treated with Phaco-NPDS, with adjunctive use of collagen matrix implant and mitomycin C (group 1), or Phaco-iStent inject (group 2). The main outcome measures were success rates [absolute success: proportion of eyes with IOP<18 mm Hg without any glaucoma medication; relative success: proportion of eyes achieving different target IOPs (<18; <15; and <12 mm Hg) with or without medication]; mean reduction (%) in IOP and medication use; number of postoperative reinterventions (goniopuncture, needling, and reoperation); and number of complications.

RESULTS

The mean age (y) was 69.3 in group 1 and 72.7 in group 2. Groups 1 (n=51) and 2 (n=32) achieved absolute success rates of 74.5% and 81.3%, respectively (P=0.333). Concerning relative success rates, no significant difference was found for IOP<18 mm Hg or an IOP<15 mm Hg between the 2 groups. However, significantly more eyes achieved an IOP <12 mm Hg in the Phaco-NPDS group. The mean percentage of IOP reduction from baseline to the end of follow-up was also statistically higher in group 1 (39.9% vs. 24.5%). Both groups achieved similar results in the mean reduction of medications per eye. No significant complications were found in either group, but patients in group 1 required more postoperative intervention than group 2.

CONCLUSIONS

Both techniques are safe and effective for the concomitant surgical treatment of open-angle glaucoma and cataracts and presented comparable relative success rates at different target IOP levels (<18 and <15 mm Hg). A larger proportion of patients in group 1 achieved a target IOP <12 mm Hg; however, more postoperative intervention was required.

摘要

摘要

非穿透性深层巩膜切除术(NPDS)和 iStent inject 联合超声乳化术均安全有效。NPDS 组的最终眼压(IOP)较低;然而,需要更多的术后干预和更长的恢复时间。

目的

本研究旨在评估第二代小梁微旁路支架植入术(iStent inject)与 NPDS 联合超声乳化术(Phaco)同期治疗开角型青光眼合并白内障的 1 年疗效和安全性。

材料与方法

这是一项单中心、纵向回顾性比较研究,纳入接受 Phaco-NPDS 治疗的患者,联合使用胶原基质植入物和丝裂霉素 C(第 1 组)或 Phaco-iStent inject(第 2 组)。主要观察指标为成功率[绝对成功率:IOP<18mmHg 且无需任何降眼压药物的眼数比例;相对成功率:IOP 达到不同目标值(<18mmHg、<15mmHg 和<12mmHg)的眼数比例,无论是否使用药物];IOP 和药物使用的平均降低率(%);术后再干预(前房穿刺、针刺和再次手术)的数量;并发症的数量。

结果

第 1 组(n=51)和第 2 组(n=32)的平均年龄(岁)分别为 69.3 和 72.7。第 1 组和第 2 组的绝对成功率分别为 74.5%和 81.3%(P=0.333)。在相对成功率方面,两组间 IOP<18mmHg 或 IOP<15mmHg 的差异无统计学意义。然而,Phaco-NPDS 组有更多的眼达到 IOP<12mmHg 的目标。从基线到随访结束时,第 1 组的 IOP 平均降低率也显著更高(39.9%比 24.5%)。两组的平均每只眼药物用量减少率相似。两组均未发现明显的并发症,但第 1 组的患者需要更多的术后干预。

结论

两种技术均安全有效,可同期治疗开角型青光眼合并白内障,在不同目标眼压水平(<18mmHg 和<15mmHg)下具有相似的相对成功率。第 1 组中有更大比例的患者达到 IOP<12mmHg 的目标;然而,需要更多的术后干预。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验